A new PET radiotracer that visualizes the enzyme primarily responsible for metabolic cholesterol degradation in the brain has been successfully validated, according to research presented at the 2023 Society of Nuclear Medicine ...
Jun 26, 2023
0
3
A new study reports the findings of the functional evaluation of six AAV vectors in 12 preclinical models of the human liver. The study, which aimed to uncover which combination of models is the most relevant for the identification ...
May 2, 2023
0
24
A recently developed amino acid compound successfully treats nonalcoholic fatty liver disease in non-human primates—bringing scientists one step closer to the first human treatment for the condition that is rapidly increasing ...
Apr 10, 2023
0
190
Earlier this year, Equatorial Guinea declared its first outbreak of Marburg virus disease, with 11 confirmed deaths so far.
Mar 24, 2023
0
47
The use of a monoclonal antibody that reduced circulating IgG levels, led to a decrease in preexisting neutralizing antibodies (NAbs) to adeno-associated virus (AAV). The study, which showed that this strategy enabled gene ...
Mar 22, 2023
0
2
New research builds upon growing evidence demonstrating the importance of rhesus macaque monkeys (Macaca mulatta) as a model for the core social impairments observed in autism spectrum disorder (ASD).
Jan 16, 2023
0
27
Oregon State University College of Pharmacy scientists have demonstrated in animal models the possibility of using lipid nanoparticles and messenger RNA, the technology underpinning COVID-19 vaccines, to treat blindness associated ...
Jan 11, 2023
0
37
Tulane University researchers are working on a new Chagas disease vaccine that prevents lasting heart damage, a long-term complication from the tropical disease.
Dec 12, 2022
0
4
Researchers from the University of Georgia have discovered a potential treatment for Chagas disease, marking the first medication with promise to successfully and safely target the parasitic infection in more than 50 years.
Sep 8, 2022
0
106
The benefits of a new COVID-19 booster that targets omicron variants far outweigh the possible risks, experts say.
Aug 25, 2022
0
25
